In cancer cells, inhibition of MEK signaling inactivates HSF1 and induces protein destabilization, aggregation, and amyloidogenesis, which induces cell toxicity, thereby contributing to the anti-tumor effect [24,46]. The gene discussed is MAP2K7; the disease is cancer.